Positron emission tomography study using probe of [11C]MeLeu

2 trials

Sponsors

Yamazaki Kana

Conditions

Pancreatic cancer

Phase 2

Efficacy and Safety of MeLeu in patients with pancreatic cancer

Active, not recruitingJPRN-jRCTs031220199

Yamazaki KanaPancreatic cancer

Start: 2022-09-06Target: 20Updated: 2026-06-29

Unknown Phase

Development of Diagnostic Imaging of Pancreatic Cancer using New PET Probe

Active, not recruitingJPRN-jRCTs031210074

Yamazaki KanaPancreatic cancer

Start: 2021-07-20Target: 10Updated: 2026-06-29